| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 4 | 2017 | 2017 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 4 | 0.582 | 0.692 | 2.0E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 2 | 2016 | 2017 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2015 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2011 | ||||||||
|
growth differentiation factor 5 | 0.511 | 0.692 | 0.67 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2011 | 2018 | ||||||||
|
transient receptor potential cation channel subfamily C member 3 | 0.570 | 0.731 | 1.1E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2016 | ||||||||
|
tRNA-Pro (anticodon TGG) 3-1 | 0.780 | 0.269 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2016 | |||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2013 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2014 | 2018 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
dopachrome tautomerase | 0.619 | 0.654 | 7.4E-14 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 2006 | 2016 | ||||||||
|
tRNA-Pro (anticodon AGG) 2-6 | 0.666 | 0.462 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 2006 | 2016 | |||||||||
|
RAN binding protein 2 | 0.578 | 0.615 | 1.00 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 2006 | 2016 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.060 | None | 0.833 | 6 | 3 | 2002 | 2020 | ||||||||
|
collagen type IX alpha 2 chain | 0.572 | 0.769 | 1.0E-08 |
|
disease | 0.090 | None | 0.889 | 9 | 3 | 2006 | 2018 | ||||||||
|
thrombospondin 2 | 0.526 | 0.769 | 0.56 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
collagen type XI alpha 1 chain | 0.495 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
asporin | 0.636 | 0.500 | 1.0E-07 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2008 | 2008 | ||||||||
|
collagen type IX alpha 3 chain | 0.569 | 0.769 | 3.3E-12 |
|
disease | 0.330 | None | 0.667 | 3 | 1 | 2006 | 2018 | ||||||||
|
cartilage intermediate layer protein | 0.736 | 0.423 | 5.4E-26 |
|
disease | 0.340 | None | 0.750 | 4 | 1 | 2005 | 2018 |